Article info

Download PDFPDF

Letter
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?

Authors

  1. Correspondence to Dr Andrew J Laster; ajlaster{at}aocc.md
View Full Text

Citation

Laster AJ, Lam GK, Gladue HS, et al
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?

Publication history

  • Accepted April 13, 2022
  • First published May 9, 2022.
Online issue publication 
May 09, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.